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Recommendations

About one out of every five women and girls aged 15 –
49 years in Kenya1 has undergone female genital
mutilation/cutting (FGM/C)—a practice that is a
violation of the rights of women and girls. The majority
of women and girls in Kenya are cut by traditional
practitioners, including traditional birth attendants
(TBAs). However, girls are now increasingly being cut
by health care providers—a practice known as the
medicalisation of FGM/C (Figure 1).1,2 Based on
intergenerational data collected from mothers,
daughters are less often cut by TBAs and other
traditional circumcisers in comparison to their mothers.

•

Awareness raising
programmes should
clarify that the
medicalisation of
FGM/C is detrimental
to the health of women
and girls.

•

Health care providers
should be trained on
the complications
associated with FGM/C
as well as legal and
human rights issues.
This training should
also address their role
in the abandonment of
the practice.

•

Health professionals’
associations and health
regulatory agencies
should have clear
guidelines and
standards for providers
that outline the
sanctions against those
who perform FGM/C.

Figure 1.Percentage of girls and women by who performed FGM/C,
2014 Kenya Demographic and Health Survey
Traditional
circumciser/TBA

83
75

15
20

Doctor/Nurse/Midwife
Don't know/Missing

2

Other

1
0

5

0

20

40

60

80

100

Percentage
Women (15-49 years)

Girls (0-14 years)

Medicalised FGM/C is carried out in hospitals, at home,
or at neutral places using surgical tools, antiseptics,
and anaesthetics.2 Some of the reasons for
medicalisation of FGM/C include the reduction of
immediate complications while allowing the women
and girls to adhere to their cultural obligations, and
financial benefits for the practitioners.2-5 Medicalisation
of FGM/C has been documented among the Kisii and
Somali communities in Kenya.3,4
This evidence brief summarises key findings from a
study6 that sought to understand the shifts in FGM/C
including medicalisation among the Kisii, Kuria, and
Somali communities in Garissa, Kisii, Migori, and
Nairobi counties.

METHODS
Data were collected using qualitative methods: key informant
interviews (KIIs), in-depth interviews (IDIs), and focus group
discussions (FGDs). KIIs were held with administrative,
religious, and community leaders, as well as health sector
stakeholders in each region. The IDIs and FGDs were
conducted among women of reproductive age, young
mothers, older women, young fathers, older men, and girls.

Why do health care providers perform FGM/C?
As illustrated in Figure 2, health care providers’ motives
for performing FGM/C centred around three issues: a
desire to reduce the negative impacts of the practice; a
fear of negative sanctions from the community if they
refuse to perform FGM/C; and medicalised FGM/C
boosts health care providers’ income.
Figure 2. Reasons why health care providers perform FGM/C
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FINDINGS
Where is medicalised FGM/C taking place?
Medicalisation was noted to be common among the Abagusii
and Somali communities. Medicalised FGM/C occurred in
both urban and rural areas but was noted to be more common
in urban areas. Although some girls were cut in private health
facilities, having the health care provider perform the cut at
home enabled families to keep the event secret.
Medicalised FGM/C was rarely reported by participants in
Kuria. The community appears to be stable, consistent, and
resistant to the shift of medicalisation. The council of elders,
who are custodians of the Kuria culture, were noted to play a
central role in selecting cutters, which might explain why girls
in the Kuria community are primarily subjected to traditional
cutting.

“Medicalised FGM/C. No, that one I have
never heard about it in our community.
It’s like a taboo for a girl to be circumcised
in hospital.”
Female, Religious leader, Kuria
Why is medicalisation increasing?
•

•
•

It is perceived to be safer because the procedure, is
reportedly performed under sterile conditions by trained
health professionals.
Medicalisation is believed to shorten the recovery period.
It is a response to the law prohibiting the practice because
it allows FGM/C to be performed in secret.

“Medicalised FGM/C allows families to cut
and hide their girls because they do not
stay for long while recuperating in the
house. For the medicalised FGM/C, no one
will even know a girl have been cut.”
40-year-old woman, Nairobi
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CONCLUSION
Study findings suggest that medicalisation is an
adaptation to awareness of health complications
associated with FGM/C and the legal banning of the
practice. These results underscore the need for antiFGM/C programmes that target health care providers.
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